Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hecker

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Frontiers in Oncology|October 20, 2022
Comparative analysis of extracellular vesicle isolation methods from human AML bone marrow cells and AML cell linesJonas B Lang, Michèle C Buck, Jennifer Rivière, et al.
Hemasphere|August 15, 2022
Genotype and Intensive Pretreatment Influence Outcome of Acute Myeloid Leukemia Patients Treated With Venetoclax in Combination With Hypomethylating Agents or Low-dose Cytarabine: "Real World" Data From GermanyKrischan Braitsch, Laura K Schmalbrock, Paul Jung, et al.
Rheumatology (Oxford, England)|December 11, 2021
Successful treatment with azacitidine in VEXAS syndrome with prominent myofasciitisIsabell Cordts, Judith S Hecker, Darja Gauck, et al.
Leukemia|March 22, 2024
Clonal hematopoiesis and its impact on the aging osteo-hematopoietic nicheSusann Winter, Katharina S Götze, Judith S Hecker, et al.
Antimicrobial Agents and Chemotherapy|December 20, 2000
Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapyO Lomovskaya, M S Warren, A Lee, et al.
Iscience|July 31, 2023
Progressive disruption of hematopoietic architecture from clonal hematopoiesis to MDSMichèle C Buck, Lisa Bast, Judith S Hecker, et al.
Human Molecular Genetics|February 18, 2022
Clonal hematopoiesis as a pitfall in germline variant interpretation in the context of Mendelian disordersTheresa Brunet, Riccardo Berutti, Veronika Dill, et al.
Blood Advances|December 1, 2022
Elevated RIPK3 correlates with disease burden in myelofibrosisVeronika Dill, Celina V Wagner, Eva C Keller, et al.
Blood Advances|August 19, 2024
Targeting CDC42 reduces skeletal degeneration after hematopoietic stem cell transplantationTheresa Landspersky, Merle Stein, Mehmet Saçma, et al.
EJNMMI Research|March 17, 2025
Liver-FDG-uptake augments early PET/CT prognostic value for CD19-targeted CAR-T cell therapy in diffuse large B cell lymphomaMichael Beck, Viktoria Blumenberg, Veit L Bücklein, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Frontiers in Oncology|October 20, 2022
Comparative analysis of extracellular vesicle isolation methods from human AML bone marrow cells and AML cell linesJonas B Lang, Michèle C Buck, Jennifer Rivière, et al.
Hemasphere|August 15, 2022
Genotype and Intensive Pretreatment Influence Outcome of Acute Myeloid Leukemia Patients Treated With Venetoclax in Combination With Hypomethylating Agents or Low-dose Cytarabine: "Real World" Data From GermanyKrischan Braitsch, Laura K Schmalbrock, Paul Jung, et al.
Rheumatology (Oxford, England)|December 11, 2021
Successful treatment with azacitidine in VEXAS syndrome with prominent myofasciitisIsabell Cordts, Judith S Hecker, Darja Gauck, et al.
Leukemia|March 22, 2024
Clonal hematopoiesis and its impact on the aging osteo-hematopoietic nicheSusann Winter, Katharina S Götze, Judith S Hecker, et al.
Antimicrobial Agents and Chemotherapy|December 20, 2000
Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapyO Lomovskaya, M S Warren, A Lee, et al.
Iscience|July 31, 2023
Progressive disruption of hematopoietic architecture from clonal hematopoiesis to MDSMichèle C Buck, Lisa Bast, Judith S Hecker, et al.
Human Molecular Genetics|February 18, 2022
Clonal hematopoiesis as a pitfall in germline variant interpretation in the context of Mendelian disordersTheresa Brunet, Riccardo Berutti, Veronika Dill, et al.
Blood Advances|December 1, 2022
Elevated RIPK3 correlates with disease burden in myelofibrosisVeronika Dill, Celina V Wagner, Eva C Keller, et al.
Blood Advances|August 19, 2024
Targeting CDC42 reduces skeletal degeneration after hematopoietic stem cell transplantationTheresa Landspersky, Merle Stein, Mehmet Saçma, et al.
EJNMMI Research|March 17, 2025
Liver-FDG-uptake augments early PET/CT prognostic value for CD19-targeted CAR-T cell therapy in diffuse large B cell lymphomaMichael Beck, Viktoria Blumenberg, Veit L Bücklein, et al.
Pageof 7